Vimarsana
Biggest News Aggregation in the World

Page 27 - Ig Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ig Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ig Group Today - Breaking & Trending Today

Ex-CNN chief Zucker backs Barclays' £1.15bn Telegraph bid - Vimarsana News

Ex-CNN chief Zucker backs Barclays' £1.15bn Telegraph bid

A vehicle run by Jeff Zucker, the former CNN chief, is backing the Barclay family's £1bn-plus bid to regain control of The Daily Telegraph.

Analysts' Updated EPS Estimates for November 15th (BAB, BATS, CI, CPG, CRMD, CTEC, ELM, EXPN, HILS, IGG) - Vimarsana News

Analysts' Updated EPS Estimates for November 15th (BAB, BATS, CI, CPG, CRMD, CTEC, ELM, EXPN, HILS, IGG)

Analysts’ updated eps estimates for Wednesday, November 15th: Babcock International Group (LON:BAB) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a GBX 550 ($6.75) target price on the stock. British American Tobacco (LON:BATS) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. […]

Lloyds spars with Barclay family over latest £1bn Telegraph exchange - Vimarsana News

Lloyds spars with Barclay family over latest £1bn Telegraph exchange

The Barclays wrote to Lloyds Banking Group again last week to reiterate an offer to repay the bulk of the debt they owe, Sky News learns.

Source: sky.com
Scotland's only gold mine on brink of collapse, says main shareholder - Vimarsana News

Scotland's only gold mine on brink of collapse, says main shareholder

A major shareholder for Scotgold Resources resigns, saying the firm is heading towards administration.

Source: bbc.co.uk
Instem bosses' windfall as takeover squeaks through - Vimarsana News

Instem bosses' windfall as takeover squeaks through

A crunch vote on the Staffordshire company's future came down to the wire but investors eventually backed the 883p per share offer from French private equity firm Archimed.